Summary
Stephanie Hilz is a scientist specializing in oncology biomarker development with nine years of experience at the intersection of wet lab biology and computational genomics. Trained as a bench scientist (PhD Cornell) and now a postdoctoral fellow turned industry scientist at Genentech and UCSF, she develops high-throughput, integrative approaches to map gene expression and alterations in three dimensions across brain tumors. She combines strong bioinformatics skills (Python, R, RNA-seq, GATK, Bioconductor, GitHub workflows) with hands-on molecular techniques, enabling end-to-end experimental design and analysis. Her work has uncovered novel microRNA links to DNA damage repair in meiosis and now focuses on spatially resolved tumor biology to predict treatment impact. An effective communicator and figure designer, she has multiple funded fellowships, international talks, and publications that translate complex genomics into actionable biomarker hypotheses. Based in San Francisco, she pairs academic rigor with industry-scale biomarker development to drive translational cancer research.
9 years of coding experience
Doctor of Philosophy (PhD), Biochemistry, Molecular, and Cell Biology, Doctor of Philosophy (PhD), Biochemistry, Molecular, and Cell Biology at Cornell University Graduate School
BS, Biochemistry, Cellular and Molecular Biology, BS, Biochemistry, Cellular and Molecular Biology at Trinity University
English, German, Chinese